Seed to Series A fund research profile
Bharat Innovation Fund is a deep-tech venture strategy built around IP-heavy businesses in healthcare, advanced technology, climate and agriculture. Its public portfolio is unusually useful for demand-side diligence because the manager names the companies and separates the fund from CIIE’s other inclusion and incubation programs.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Bharat Innovation Fund uses a seed to series a; deep-tech venture capital approach across Healthcare, advanced technology, climate and agriculture.
Current evidence
Independent 2024–2026 transaction evidence identifies current Bharat Innovation Fund activity involving Clodura.AI, Portl, BGauss, ClaimBuddy and Zumutor Biologics, while the official fund pages maintain its portfolio and team.
Strategy
Seed to Series A; deep-tech venture capital
Sector focus
Healthcare, advanced technology, climate and agriculture
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Independent 2024–2026 transaction evidence identifies current Bharat Innovation Fund activity involving Clodura.AI, Portl, BGauss, ClaimBuddy and Zumutor Biologics, while the official fund pages maintain its portfolio and team.
Investor questions
Bharat Innovation Fund is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Seed to Series A; deep-tech venture capital, with a sector focus of Healthcare, advanced technology, climate and agriculture. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Bharat Innovation Fund in the reviewed public sources: FireCompass, CreditVidya, Detect Technologies, Entropik Tech, PlayShifu, vPhrase, Zumutor Biologics, Nayam Innovations, A5G Networks, Human Edge, Terra, Algorithmic Biologics, Portl, Clodura.AI, BGauss, ClaimBuddy. It does not represent a complete current portfolio unless the manager has published one.
The official portfolio identifies FireCompass, CreditVidya, Detect Technologies, Entropik Tech, PlayShifu, Zumutor Biologics, Portl and Clodura.AI. Independent 2024–2026 transaction databases also identify Clodura.AI, Portl, BGauss, ClaimBuddy and Zumutor activity; fund-level audited returns are not publicly disclosed. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: The fund corpus and current AUM are not publicly disclosed; public ecosystem reporting describes an inaugural $100 million vehicle and later fundraising activity, but this record does not treat targets as closed capital.. Public terms or access information: Seed and Series A deep-tech investing; cheque sizes, fees, carry, hurdle, fund term, recycling and liquidity terms are not publicly disclosed.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Kunal Upadhyay; Shyam Menon; Ashwin Raguraman; Som Pal Choudhury; Rohan Choukkar. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Fund-level audited returns, current NAV, ownership percentages, follow-on reserves and complete fee/carry terms are not publicly disclosed. The record is limited to Bharat Innovation Fund and does not aggregate Bharat Inclusion Seed Fund or other CIIE programs..
2026-06-13: Independent 2024–2026 transaction evidence identifies current Bharat Innovation Fund activity involving Clodura.AI, Portl, BGauss, ClaimBuddy and Zumutor Biologics, while the official fund pages maintain its portfolio and team.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.